Association of COVID with Mycosis in General

G Kaur, R Kaur, M Kaur - Infectious Disorders-Drug Targets …, 2024 - ingentaconnect.com
Background: The COVID-19 pandemic caused by SARS-CoV-2 is a respiratory disease
which created havoc worldwide, was accompanied by another peculiar, otherwise rare …

[PDF][PDF] Investigation on the relationship between serum periostin, MMP-7, TGF-β, and IL-18 levels and the clinical course and prognosis of COVID-19.

ME Tuna, B Kerget, A Aksakal… - European Review for …, 2024 - europeanreview.org
OBJECTIVE: Cytokines are involved in the inflammatory/anti-inflammatory balance and have
been shown to play an important role in the course of COVID-19. This study aimed to …

Quantitative plasma proteomics of survivor and non-survivor COVID-19 patients admitted to hospital unravels potential prognostic biomarkers and therapeutic targets

DC Flora, AD Valle, HABS Pereira, TF Garbieri… - MedRxiv, 2021 - medrxiv.org
The development of new approaches that allow early assessment of which cases of COVID-
19 will likely become critical and the discovery of new therapeutic targets are urgent …

[HTML][HTML] Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital

JI Iglesias, AV Vassallo, JB Sullivan… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Our understanding of the severe acute respiratory syndrome coronavirus 2
has evolved since the first reported cases in December 2019, and a greater emphasis has …

实体器官移植受者感染新型冠状病毒的诊疗策略.

巨春蓉, 徐鑫, 薛武军 - Organ Transplantation/Qi Guan Yi …, 2023 - search.ebscohost.com
实体器官移植受者(SOTR) 由于长期服用免疫抑制药, 属于各种病原体感染的高危人群,
包括新型冠状病毒(新冠病毒). 另外, SOTR 往往伴有高血压, 糖尿病等慢性基础疾病 …

Distinguishing incubation and acute disease stages of mild-to-moderate COVID-19

M Müller, J Volzke, B Subin, CJ Schmidt… - Viruses, 2022 - mdpi.com
While numerous studies have already compared the immune responses against SARS-CoV-
2 in severely and mild-to-moderately ill COVID-19 patients, longitudinal trajectories are still …

[HTML][HTML] 重型/危重型新型冠状病毒肺炎( COVID-19) 患者凝血功能障碍与细胞因子风暴综合征关系的研究进展

张婕, 高晓玲, 杨林花 - Chinese Journal of Hematology, 2021 - ncbi.nlm.nih.gov
张婕1 高晓玲2 杨林花3 1 山西医科大学, 太原030001; 2 山西医科大学第二医院呼吸与危重症
医学科, 太原030001; 3 山西医科大学第二医院血液科, 太原030001 通信作者: 杨林花, Email …

Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis

FM Uckun, M Saeed, M Awili, IH Ozercan… - Future …, 2022 - Future Medicine
Aim: Our main objectives were to compare the effects of Rejuveinix (RJX), dexamethasone
(DEX) and their combination on the severity of sepsis and survival outcome in an animal …

[HTML][HTML] Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report

M Di Palma, E Gentilini, C Masucci… - … journal of hematology …, 2022 - ncbi.nlm.nih.gov
Management of patients with concomitant acute lymphoblastic leukemia (ALL) and COVID-
19 infection is challenging. We describe the clinical history of a 40-year-old male with …

Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19

FM Uckun, M Saeed, M Awili, IH Ozercan, S Qazi… - medRxiv, 2022 - medrxiv.org
Background The identification of effective strategies capable of reducing the case mortality
rate of high-risk COVID-19 is an urgent and unmet medical need. We recently reported the …